We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 282 results
  1. Recurrent Vulvovaginal Candidiasis: Assessing the relationship between feminine/vaginal washes and other factors among Ghanaian women

    Introduction

    Vulvovaginal Candidiasis (VVC) is a public health problem, with approximately 30–50% of women affected at least once during their...

    Emmanuel Otoo-Annan, Vivian Efua Senoo-Dogbey in BMC Public Health
    Article Open access 05 January 2024
  2. Vulvovaginal Candidiasis in Postmenopausal Women

    Purpose of Review

    Vulvovaginal candidiasis (VVC) is one of the most common vaginal infections worldwide, but limited evidence-based data is available...

    Mariel Becker, Ryan Sobel in Current Infectious Disease Reports
    Article 09 March 2023
  3. Role of Obesity in Recurrent Vulvovaginal Symptoms and Disease

    Purpose of Review

    To highlight recent literature that discusses the association of overweight and obesity with vaginal dysbiosis and symptomatic...

    Anna Maya Powell, Isabella Sarria, Oluwatosin Goje in Current Infectious Disease Reports
    Article 27 December 2022
  4. Lived experience of medical management in recurrent vulvovaginal candidiasis: a qualitative study of an uncertain journey

    Background

    Recurrent vulvovaginal candidiasis (RVVC) is experienced by up to 10% of pre-menopausal women globally, yet there is limited research...

    Moira Bradfield Strydom, Ramesh L. Walpola, ... Evelin Tiralongo in BMC Women's Health
    Article Open access 19 September 2022
  5. Lipid-based amphotericin B gel treatment eradicates vulvovaginal candidiasis in patients who failed to azole therapy

    Vaginal yeast infection is one of the most common diseases caused by vulvovaginal candidiasis (VVC). Effective therapy for VVC is needed. A...

    Saifuddin Sheikh, Ateeq Ahmad, ... Imran Ahmad in Archives of Dermatological Research
    Article 01 March 2023
  6. Efficacy and safety of oral ibrexafungerp in Chinese patients with vulvovaginal candidiasis: a phase III, randomized, double-blind study

    Purpose

    To evaluate the efficacy and safety of oral ibrexafungerp (HS-10366) versus placebo in Chinese patients with vulvovaginal candidiasis (VVC).

    ...
    ** Liao in Infection
    Article Open access 03 April 2024
  7. Design and evaluation of antifungal vaginal suppository using coconut oil as base for vulvovaginal candidiasis

    Background

    The emergence of antimicrobial resistance to antifungals has made vulvovaginal candidiasis a concern. Coconut oil has antimycotic...

    Ayomide D. Mustapha, Folusho M. Oyedepo, ... Oluwatoyin A. Odeku in Future Journal of Pharmaceutical Sciences
    Article Open access 18 September 2023
  8. Role of Antifungal Susceptibility Tests in the Treatment of Vulvovaginal Candidiasis

    Purpose of Review

    The increased prevalence of antifungal drug resistance associated with common vaginal pathogen C. albicans as well as non- albicans...

    Article 22 February 2023
  9. Barriers and facilitators of adherence to treatment among women with vulvovaginal candidiasis: a qualitative study

    Background

    Non-adherence of patients with vulvovaginal candidiasis (VVC) to treatment recommendations leads to treatment failure and recurrence of...

    Maryam Erfaninejad, Arash Salahshouri, Nasrin Amirrajab in European Journal of Medical Research
    Article Open access 21 December 2022
  10. Survey of incidence, lifetime prevalence, and treatment of self-reported vulvovaginal candidiasis, United States, 2020

    Background

    Vulvovaginal candidiasis (VVC) is a common gynecologic problem in the United States but estimates of its true incidence and prevalence are...

    Kaitlin Benedict, Alyson L. Singleton, ... Noelle Angelique M. Molinari in BMC Women's Health
    Article Open access 10 May 2022
  11. Vulvovaginal Candidiasis: Epidemiology and Risk Factors, Pathogenesis, Resistance, and New Therapeutic Options

    Purpose of Review

    Vulvovaginal candidiasis (VVC) is an infection of the vaginal mucosa caused by fungi of the genus Candida and can become pathogenic...

    Janaina de Cássia Orlandi Sardi, Diego Romário Silva, ... José Francisco Hofling in Current Fungal Infection Reports
    Article 22 February 2021
  12. Invasive candidiasis

    Invasive candidiasis is an important fungal disease caused by Candida albicans and, increasingly, non- albicans Candida pathogens. Invasive Candida ...

    Cornelia Lass-Flörl, Souha S. Kanj, ... Miriam Alisa Govrins in Nature Reviews Disease Primers
    Article 21 March 2024
  13. First detection of mutated ERG11 gene in vulvovaginal Candida albicans isolates at Ouagadougou/Burkina Faso

    Background

    Vulvovaginal candidiasis is an important cause of morbidity among women due to Candida species. In the last decades, resistance to azoles,...

    Essi Etonam Dovo, Théodora Mahoukèdè Zohoncon, ... Jacques Simpore in BMC Infectious Diseases
    Article Open access 08 August 2022
  14. Vulvovaginal yeast infections, gestational diabetes and pregnancy outcome

    Background

    The primary aim was to evaluate the association between gestational diabetes and blood glucose levels and vulvovaginal yeast infections in...

    Leeni Blomberg, Katri Backman, ... Leea Keski-Nisula in BMC Pregnancy and Childbirth
    Article Open access 26 January 2023
  15. Candidiasis profile at the outpatient department of the university of cape coast hospital in the central region of Ghana: a retrospective study

    Introduction

    Vulvovaginal candidiasis (VVC) is a public health problem with an estimated 138 million women globally experiencing recurrent VVC...

    Kwame Kumi Asare, Hilda Amuaku Bentil, ... Yeboah Kwaku Opoku in BMC Women's Health
    Article Open access 10 March 2023
  16. Ethnobotanical study of medicinal plants utilized in the management of candidiasis in Northern Uganda

    Background

    The emergence of resistant Candida species to antifungal drugs has led to resurgence in herbal usage globally. However, little is known...

    Betty Akwongo, Esther Katuura, ... Esezah Kyomugisha Kakudidi in Tropical Medicine and Health
    Article Open access 14 October 2022
  17. Candidiasis and Other Emerging Yeasts

    Purpose of Review

    The review presents a comprehensive and updated information on the contemporary status of invasive candidiasis (IC), other emerging...

    Megha Sharma, Arunaloke Chakrabarti in Current Fungal Infection Reports
    Article 31 January 2023
  18. Sertaconazole 300 mg versus clotrimazole 500 mg vaginal suppository for treating pregnant women with acute vaginal candidiasis: a double-blinded, randomized trial

    Background

    Vaginal candidiasis (VC) commonly affects pregnant women. Traditionally, clotrimazole vaginal tablets (CLO) have been the cornerstone of...

    Chenchit Chayachinda, Manopchai Thamkhantho, ... Chanakarn Klerdklinhom in BMC Pregnancy and Childbirth
    Article Open access 04 April 2024
  19. Evaluation and optimization of the syndromic management of female genital tract infections in Nairobi, Kenya

    Background

    Genital tract infections pose a public health concern. In many low-middle-income countries, symptom-based algorithms guide treatment...

    Gloria S. Omosa-Manyonyi, Marloes de Kam, ... Jaap ten Oever in BMC Infectious Diseases
    Article Open access 22 August 2023
  20. A Practical Guide to the Management of Oral Candidiasis in Patients with Plaque Psoriasis Receiving Treatments That Target Interleukin-17

    Plaque psoriasis is an immune-mediated inflammatory skin disease associated with the dysregulation of cytokines, especially those involved in the...

    April W. Armstrong, Andrew Blauvelt, ... Richard B. Warren in Dermatology and Therapy
    Article Open access 15 February 2022
Did you find what you were looking for? Share feedback.